The DOI matches its Crossref record.
Angiographic Surrogate End Points in Drug-Eluting Stent Trials
Open accessAbstract
OBJECTIVES We sought to validate 4 angiographic measures as potential surrogates for clinical restenosis (target lesion revascularization [TLR]) after stent implantation. BACKGROUND Given the low revascularization rates with drug-eluting stents (DES), an angiographic surrogate of TLR is desirable to reduce the sample size required to demonstrate efficacy in future trials of antirestenosis devices. METHODS We evaluated 4 potential angiographic measures (late loss [LL] and percent diameter stenosis [%DS], both in-stent and in-segment) as a surrogate for TLR at 1 year. From 11 multicenter, prospective randomized stent trials, 9 comparing DES with bare-metal stents (BMS) and 2 comparing different DES, individual data on 5,381 patients with a single treated lesion and follow-up angiography at 6 to 9 months were analyzed. RESULTS By 4 well-defined criteria of surrogacy, LL and %DS strongly predicted the risk of TLR, with in-segment %DS being the most highly predictive (approximately 0.95). Differences in TLR risk were fully explained statistically by their differences in LL or %DS, although LL as a surrogate was dependent on vessel size whereas %DS was not. However, because of the curvilinearity of the logistic model, trials comparing 2 effective DES can have significant differences in mean LL and %DS but small expected differences in TLR risk, especially at the lower ranges of LL and %DS. CONCLUSIONS From in-stent and in-segment LL and %DS measures, logistic models can reliably estimate TLR rates for DES and BMS. These angiographic measures are thus suitable surrogate markers for clinical stent efficacy and can be used as primary end points in future DES trials to significantly reduce sample size.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Guidelines on myocardial revascularization
The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.08.019 · Cited by 1,004
Stone, G. W. (2008) · JAMA · doi:10.1001/jama.299.16.1903 · Cited by 582
Self-citationGarg, S., & Serruys, P. W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.007 · Cited by 501
Byrne, R. A., Neumann, F.-J., Mehilli, J., Pinieck, S., Wolff, B., Tiroch, K., Schulz, S., Fusaro, M., Ott, I., Ibrahim, T., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61964-3 · Cited by 459
Metadata
- Authors
- Pocock, S. J., Lansky, A. J., Mehran, R., Popma, J. J., Fahy, M. P., Na, Y., Dangas, G., Moses, J. W., Pucelikova, T., Kandzari, D. E., Ellis, S. G., Leon, M. B., & Stone, G. W.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 51
- Issue
- 1
- Pages
- 23-32
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1428162896
- Cited by
- 162
- References
- 0
- FWCI
- 21.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Angiographic Surrogate End Points in Drug-Eluting Stent Trials. https://app.cochat.ai/papers/10.1016/j.jacc.2007.07.084
- The paper
- Pocock, S. J., Lansky, A. J., Mehran, R., Popma, J. J., Fahy, M. P., Na, Y., Dangas, G., Moses, J. W., Pucelikova, T., Kandzari, D. E., Ellis, S. G., Leon, M. B., & Stone, G. W. (2008). Angiographic Surrogate End Points in Drug-Eluting Stent Trials. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2007.07.084
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.